Longitudinal care of a community-based cohort of patients with rheumatoid arthritis (RA) was evaluated
retrospectively. Candidate determinants of disability included visual analog scales (VAS) for patient global assessment
and pain, comorbidities, and medications. The outcome was the ‘patient-acceptable symptom state’ for disability as
defined by the Health Assessment Questionnaire (HAQ) disability index, using a cutoff of <1.04. Two-sample t tests and
multivariable logistic regression were used to determine odds ratios (OR) for associations between predictor variables and
disability. Out of a total of 99 patients, 28 (28%) patients had HAQ ≥1.04 at their last visit. The greatest odds of not
attaining the patient-acceptable symptom state in a multivariable model was associated with corticosteroids (OR: 5.1;
p=0.02), antidepressants (OR: 5.3; p=0.02), and female sex (OR: 6.5; p=0.05). In the era of biologic therapy, female sex,
corticosteroids, and antidepressants remain profound determinants of disability highlighting the need to understand the
underlying mechanisms.